EverFlex® Self-Expanding Stent System
Flexibility Sustained: Durability Delivered
The helical design of the EverFlex Stent provides flexibility that cannot be achieved with traditional stents. Key features of the EverFlex stent family include:
- Precision—proprietary EX.P.R.T.™ Deployment System secures the stent to essentially eliminate premature deployment or “jumping”
- Clear Visibility—tantalum GPS™ markers enhance visibility for easier, more precise positioning
- Convenience—broad offering of stent lengths: 20mm to 200mm
The DURABILITY II IDE Study is being performed at several hospitals in the United States to support U.S. peripheral approval of the EverFlex stent. The objective of the study is to evaluate the safety and effectiveness of the EverFlex stent compared to percutaneous transluminal angioplasty (PTA) performance goals in patients who have stenosis (blockages) in the superficial femoral artery (SFA), which is located in the upper leg between the groin and knee. We expect to complete patient enrollment in the DURABILITY II study in 2010.
Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
Note: The EverFlex® Self-Expanding Biliary Stent System is intended as a palliative treatment of malignant neoplasms in the biliary tree within the United States. WARNING: The safety and effectiveness of this device for use in the vascular system have not been established.
Print
